 Conference Call Scheduled for Tuesday, February 15 at 11:30 AM EST NORTHVALE, NJ ACCESSWIRE February 14, 2022 Elite Pharmaceuticals, Inc. Elite or the CompanyOTCQB:ELTP, a specialty pharmaceutical company developing niche generic products, announced results for the third quarter of fiscal year 2022 ended December 31, 2021 Third Quarter. Consolidated revenues for the Third Quarter were 9.0 million, an increase of 2.9 million or 48 as compared to the corresponding period of the prior year, primarily due to stronger sales of Amphetamine IR Tablets and Amphetamine ER Capsules. 